Jerry Moran actually said...

You indicated in your testimony and in part in response to my questions that often substance within the application process, substance withi...

Is there a common denominator for drug companies who are required to submit additional information during the approval process?

Can you report anything about the status of those negotiations, or is that beyond your----

I hope our focus in this hearing will continue to be how do we make certain that FDA is doing its job well.